The involvement of phosphatase and tensin homolog deleted on chromosome ten (PTEN) in the regulation of inflammation following coronary microembolization

Cellular Physiology and Biochemistry

Volumn 33, Issue 6, 2014, Pages 1963-1974

  Wang, Jiangyou ^a   Li, Lang ^a   Su, Qiang ^a   Zhou, You ^a   Chen, Han ^b   Ma, Guotian ^a   Liu, Tao ^a   Tang, Zhongli ^a   Liu, Yangchun ^a  

^a FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

^b WUHAN ASIA HEART HOSPITAL   (China)

Author keywords

Coronary microembolization; Inflammation; PTEN; TNF

Indexed keywords

MICROSPHERE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SMALL INTERFERING RNA; TROPONIN I; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ARTIFICIAL EMBOLISM; CONTROLLED STUDY; CORONARY MICROEMBOLIZATION; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEART INFARCTION SIZE; IMMUNOCHEMISTRY; INFLAMMATION; INJECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MINIPIG; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CORONARY ARTERY THROMBOSIS; GENETICS; HEART INFARCTION; HEART MUSCLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PIG; RNA INTERFERENCE; TIME;

SUIDAE;

ANIMALS; BLOTTING, WESTERN; CORONARY THROMBOSIS; ECHOCARDIOGRAPHY; FEMALE; INFLAMMATION; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PTEN PHOSPHOHYDROLASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SWINE; SWINE, MINIATURE; TIME FACTORS; TROPONIN I; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84903874434     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000362973     Document Type: Article

References (25)

1. Falk E: Plaque rupture with severe pre-existing stenosis precipitating coronary thrombosis. Characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-134.
2. Davies MJ, Thomas AC: Plaque fissuring-The cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J 1985;53:363-373.
3. Falk E: Unstable angina with fatal outcome: Dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation 1985;71:699-708.
4. Skyschally A, Schulz R, Erbel R, Heusch G: Reduced coronary and inotropic reserves with coronary microembolization. Am J Physiol Heart Circ Physiol 2002;282:H611-H614.
5. Dorge H, Neumann T, Behrends M, Skyschally A, Schulz R, Kasper C, Erbel R, Heusch G: Perfusion-contraction mismatch with coronary microvascular obstruction: Role of inflammation. Am J Physiol Heart Circ Physiol 2000;279:H2587-H2592.
6. Dorge H, Schulz R, Belosjorow S, Post H, van de Sand A, Konietzka I, Frede S, Hartung T, Vinten-Johansen J, Youker KA, Entman ML, Erbel R, Heusch G: Coronary microembolization: The role of tnf-Alpha in contractile dysfunction. J Mol Cell Cardiol 2002;34:51-62.
7. Thielmann M, Dorge H, Martin C, Belosjorow S, Schwanke U, van De Sand A, Konietzka I, Buchert A, Kruger A, Schulz R, Heusch G: Myocardial dysfunction with coronary microembolization: Signal transduction through a sequence of nitric oxide, tumor necrosis factor-Alpha, and sphingosine. Circ Res 2002;90:807-813.
8. Canton M, Skyschally A, Menabo R, Boengler K, Gres P, Schulz R, Haude M, Erbel R, Di Lisa F, Heusch G: Oxidative modification of tropomyosin and myocardial dysfunction following coronary microembolization. Eur Heart J 2006;27:875-881.
9. Skyschally A, Gres P, Hoffmann S, Haude M, Erbel R, Schulz R, Heusch G: Bidirectional role of tumor necrosis factor-Alpha in coronary microembolization: Progressive contractile dysfunction versus delayed protection against infarction. Circ Res 2007;100:140-146.
10. Li L, Zhao X, Lu Y, Huang W, Wen W: Altered expression of pro-And anti-inflammatory cytokines is associated with reduced cardiac function in rats following coronary microembolization. Mol Cell Biochem 2010;342:183-190.
11. Li L, Li DH, Qu N, Wen WM, Huang WQ: The role of erk1/2 signaling pathway in coronary microembolization-induced rat myocardial inflammation and injury. Cardiology 2010;117:207-215.
12. Siddall HK, Warrell CE, Yellon DM, Mocanu MM: Ischemia-reperfusion injury and cardioprotection: Investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency. Basic Res Cardiol 2008;103:560-568.
13. Keyes KT, Xu J, Long B, Zhang C, Hu Z, Ye Y: Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction. Am J Physiol Heart Circ Physiol 2010;298:H1198-H1208.
14. Oudit GY, Kassiri Z, Zhou J, Liu QC, Liu PP, Backx PH, Dawood F, Crackower MA, Scholey JW, Penninger JM: Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. Cardiovasc Res 2008;78:505-514.
15. Furgeson SB, Simpson PA, Park I, Vanputten V, Horita H, Kontos CD, Nemenoff RA, Weiser-Evans MC: Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Cardiovasc Res 2010;86:274-282.
16. Carlsson M, Wilson M, Martin AJ, Saeed M: Myocardial microinfarction after coronary microembolization in swine: MR imaging characterization. Radiology 2009;250:703-713.
17. Chen CH, Jiang Z, Yan JH, Yang L, Wang K, Chen YY, Han JY, Zhang JH, Zhou CM: The involvement of programmed cell death 5 (PDCD5) in the regulation of apoptosis in cerebral ischemia/reperfusion injury. CNS Neurosci Ther 2013;19:566-576.
18. Heusch G, Kleinbongard P, Bose D, Levkau B, Haude M, Schulz R, Erbel R: Coronary microembolization: From bedside to bench and back to bedside. Circulation 2009;120:1822-1836.
19. Rioufol G, Gilard M, Finet G, Ginon I, Boschat J, Andre-Fouet X: Evolution of spontaneous atherosclerotic plaque rupture with medical therapy: Long-term follow-up with intravascular ultrasound. Circulation 2004;110:2875-2880.
20. Skyschally A, Schulz R, Gres P, Konietzka I, Martin C, Haude M, Erbel R, Heusch G: Coronary microembolization does not induce acute preconditioning against infarction in pigs-The role of adenosine. Cardiovasc Res 2004;63:313-322.
21. Arras M, Strasser R, Mohri M, Doll R, Eckert P, Schaper W, Schaper J: Tumor necrosis factor-Alpha is expressed by monocytes/macrophages following cardiac microembolization and is antagonized by cyclosporine. Basic Res Cardiol 1998;93:97-107.
22. Skyschally A, Haude M, Dorge H, Thielmann M, Duschin A, van de Sand A, Konietzka I, Buchert A, Aker S, Massoudy P, Schulz R, Erbel R, Heusch G: Glucocorticoid treatment prevents progressive myocardial dysfunction resulting from experimental coronary microembolization. Circulation 2004;109:2337-2342.
23. Yamada KM, Araki M: Tumor suppressor PTEN: Modulator of cell signaling, growth, migration and apoptosis. J Cell Sci 2001;114:2375-2382.
24. Oudit GY, Sun H, Kerfant BG, Crackower MA, Penninger JM, Backx PH: The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease. J Mol Cell Cardiol 2004;37:449-471.
25. Schabbauer G, Matt U, Gunzl P, Warszawska J, Furtner T, Hainzl E, Elbau I, Mesteri I, Doninger B, Binder BR, Knapp S: Myeloid PTEN promotes inflammation but impairs bactericidal activities during murine pneumococcal pneumonia. J Immunol 2010;185:468-476.